Active, not recruiting
Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer
NCT06766019
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China